Silver Book Fact

There are 23 medicines in development for stroke, the third leading cause of death after heart disease and cancer.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.  
  • Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.  
  • Stroke prevention through optimal anticoagulation
    If half of atrial fibrillation patients who currently receive warfarin in a routine care setting had their anti-coagulation optimized, around 9,000 strokes and more than 29,000 bleeds would be prevented.  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • In 2005, an estimated 1,271,000 inpatient angioplasty procedures, 469,000 inpatient bypass procedures, 1,322,000 inpatient diagnostic cardiac catheterizations, 91,000 inpatient implantable defibrillators, and 180,000 pacemaker procedures were performed for inpatients in the…